A five-year, $7.5 million grant will fund an initiative to use technology to create reliable tools to advance the development of drugs.

The oral medication allows new mothers to be treated and recover at home.

A School of Public Health study shows exposure to ultrafine particles during pregnancy enhances the risk for respiratory viral infection.

A School of Pharmacy lab has secured a biomarker patent in its search for better detection and treatment of the dangerous pregnancy complication.

Texas A&M research highlights the need to expand prepregnancy messaging to emphasize the reproductive dangers of alcohol use by both parents.

Tiny particles in air pollution affect important lipid transport genes in the placenta, showing how exposure may cause conditions like preeclampsia and low birth weight.

A Texas A&M clinical assistant professor shares what's known so far about COVID-19 and the risks to pregnant women.

Texas A&M College of Medicine professor Dr. D. Samba Reddy's research helped develop first-in-class medicine for the brain condition postpartum depression.